advanced search
2023 June Inhalation HW Boston
Jamie Clayton
Managing Director
Copley Scientific

Is this your profile?

About

Jamie Clayton is Managing Director of Copley Scientific. Until December 2022 he was Operations Director at Freeman Technology. He graduated from University of Sheffield with a degree in control engineering.

Mr Clayton has previously worked as a mentor with several academic groups and is an active member of ASTM F42. He is also a regular contributor to conferences and workshops on the topic of powder rheology.

Contributions

EXPERT VIEW
POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY
Jamie Clayton, Joana Pinto and Sarah Zellnitz discuss the benefits of multi-faceted powder characterisation in dry powder inhalation formulations and how it can support efforts to achieve net zero emissions.

More contributions

EXPERT VIEW
ANALYTICAL TECHNIQUES FOR THE FORMULATION OF GASTRORETENTIVE TABLETS
Jamie Clayton, Phil Bone and Kyu Mok Hwang discuss the value of analyses such as mercury porosimetry and powder rheology in characterising excipients for gastroretentive tablet formulation, and go on to detail a case study investigating polymer excipients for a novel bilayer floating tablet.
EXPERT VIEW
3D PRINTING DRUGS: LEARNING FROM THE PIONEERS
Jamie Clayton reviews the potential of 3D printing as a pharmaceutical production method and looks at the associated implications for formulation development, focusing on powder-based printing. He examines what leading experts now understand about how to specify powder feeds for 3D printing.
EXPERT VIEW
CHOOSING THE RIGHT DOSATOR FOR DPI DOSING
Jamie Clayton, Rajeev Dattani and Dave Seaward discuss the operation of dosators for reliable and accurate filling of DPI capsules and blisters.
Top